Peroxisome Proliferator-Activated Receptor α Antagonism Inhibits Hepatitis C Virus Replication

Chemistry & Biology - Tập 13 - Trang 23-30 - 2006
Bojana Rakic1,2, Selena M. Sagan1, Matthew Noestheden1,2, Sylvie Bélanger1, Xiaolin Nan3, Conor L. Evans3, X. Sunney Xie3, John Paul Pezacki1,2
1The Steacie Institute for Molecular Sciences, The National Research Council of Canada, Ottawa, Ontario K1A 0R6, Canada
2Department of Chemistry, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada
3Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138

Tài liệu tham khảo

Bigger, 2001, DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection, J. Virol., 75, 7059, 10.1128/JVI.75.15.7059-7066.2001

McCaffrey, 2002, Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice, Mol. Ther., 5, 676, 10.1006/mthe.2002.0600

Wasley, 2000, Epidemiology of hepatitis C: geographic differences and temporal trends, Semin. Liver Dis., 20, 1, 10.1055/s-2000-9506

Bradley, 1999, Hepatitis viruses: their role in human cancer, Proc. Assoc. Am. Physicians, 111, 588, 10.1046/j.1525-1381.1999.t01-1-99240.x

Christie, 1999, Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus, Hepatology, 30, 1037, 10.1002/hep.510300403

Alter, 1992, The natural-history of community-acquired hepatitis-C in the United States, N. Engl. J. Med., 327, 1899, 10.1056/NEJM199212313272702

Su, 2002, Genomic analysis of the host response to hepatitis C virus infection, Proc. Natl. Acad. Sci. USA, 99, 15669, 10.1073/pnas.202608199

Ye, 2003, Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation, Proc. Natl. Acad. Sci. USA, 100, 15865, 10.1073/pnas.2237238100

Moradpour, 2003, Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex, Antiviral Res., 60, 103, 10.1016/j.antiviral.2003.08.017

Gosert, 2003, Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons, J. Virol., 77, 5487, 10.1128/JVI.77.9.5487-5492.2003

Hope, 2000, Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein, J. Gen. Virol., 81, 1913, 10.1099/0022-1317-81-8-1913

Shi, 2002, Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins, Virology, 292, 198, 10.1006/viro.2001.1225

Friebe, 2005, Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication, J. Virol., 79, 380, 10.1128/JVI.79.1.380-392.2005

Moradpour, 2004, Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication, J. Virol., 78, 13278, 10.1128/JVI.78.23.13278-13284.2004

Issemann, 1990, Activation of a member of the steroid-hormone receptor superfamily by peroxisome proliferators, Nature, 347, 645, 10.1038/347645a0

Auboeuf, 1997, Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: no alteration in adipose tissue of obese and NIDDM patients, Diabetes, 46, 1319, 10.2337/diab.46.8.1319

Kliewer, 1992, Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors, Nature, 358, 771, 10.1038/358771a0

Hertz, 1995, Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III, J. Biol. Chem., 270, 13470, 10.1074/jbc.270.22.13470

Lee, 2002, T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities, J. Biol. Chem., 277, 19649, 10.1074/jbc.M200743200

Kliewer, 1997, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ, Proc. Natl. Acad. Sci. USA, 94, 4318, 10.1073/pnas.94.9.4318

Everett, 2000, The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease, Liver, 20, 191, 10.1034/j.1600-0676.2000.020003191.x

Xu, 2001, Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors, Proc. Natl. Acad. Sci. USA, 98, 13919, 10.1073/pnas.241410198

Oliver, 2001, A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport, Proc. Natl. Acad. Sci. USA, 98, 5306, 10.1073/pnas.091021198

Kersten, 1999, Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting, J. Clin. Invest., 103, 1489, 10.1172/JCI6223

Wan, 2000, Peroxisome proliferator-activated receptor α-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice, J. Biol. Chem., 275, 28285, 10.1074/jbc.M000934200

Cheng, 2004, Coherent anti-Stokes Raman scattering microscopy: instrumentation, theory, and applications, J. Phys. Chem. B, 108, 827, 10.1021/jp035693v

Evans, 2005, Chemical imaging of tissue in vivo with video-rate coherent anti-Stokes Raman Scattering microscopy, Proc. Natl. Acad. Sci. USA, 102, 16807, 10.1073/pnas.0508282102

Reigadas, 2001, HCV RNA-dependent RNA polymerase replicates in vitro the 3′ terminal region of the minus-strand viral RNA more efficiently than the 3′ terminal region of the plus RNA, Eur. J. Biochem., 268, 5857, 10.1046/j.0014-2956.2001.02532.x

Takigawa, 2004, Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome, Microbiol. Immunol., 48, 591, 10.1111/j.1348-0421.2004.tb03556.x

Shi, 2003, Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that coffactionates with caveolin-2, J. Virol., 77, 4160, 10.1128/JVI.77.7.4160-4168.2003

McCarthy, 2004, Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-α target gene activation, J. Pharmacol. Exp. Ther., 311, 864, 10.1124/jpet.104.072785

Miller, 1996, Effect on the expression of c-met, c-myc and PPAR-α in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643, Carcinogenesis, 17, 1337, 10.1093/carcin/17.6.1337

Anderson, 2004, Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver, Mol. Pharmacol., 66, 1440, 10.1124/mol.104.005496

Hashimoto, 2000, Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting, J. Biol. Chem., 275, 28918, 10.1074/jbc.M910350199

Kapadia, 2005, Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids, Proc. Natl. Acad. Sci. USA, 102, 2561, 10.1073/pnas.0409834102

Grimbert, 1994, Acute hepatitis induced by Hmg-Coa reductase inhibitor, lovastatin, Dig. Dis. Sci., 39, 2032, 10.1007/BF02088142